C4 article: Implications of COVID-19 in transplantation

Contributors to the C4 article

Research output: Contribution to journalArticlepeer-review

16 Scopus citations


A novel coronavirus has had global impact on individual health and health care delivery. In this C4 article, contributors discuss various aspects of transplantation including donor and recipient screening, management of infected patients, and prevention of coronavirus disease (COVID). Donor screening with SARS-CoV-2 nucleic acid testing (NAT) close to the time of procurement is recommended. Many programs are also screening all potential recipients at the time of admission. The management of COVID has evolved with remdesivir emerging as a new potential option for transplant recipients. Dexamethasone has also shown promise and convalescent plasma is under study. Prevention strategies for transplant candidates and recipients are paramount. Pediatric-specific issues are also discussed. Strategies for the psychological well-being of patients and providers are also imperative, in addition to future research priorities for transplantation.

Original languageEnglish (US)
Pages (from-to)1801-1815
Number of pages15
JournalAmerican Journal of Transplantation
Issue number5
StatePublished - May 2021


  • clinical research/practice
  • infection and infectious agents
  • infection and infectious agents – viral
  • infectious disease
  • organ transplantation in general

ASJC Scopus subject areas

  • Immunology and Allergy
  • Transplantation
  • Pharmacology (medical)


Dive into the research topics of 'C4 article: Implications of COVID-19 in transplantation'. Together they form a unique fingerprint.

Cite this